BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

760346

544647

NEPHROPLUS

img img img img
No Data Available

Nephrocare Health Services Ltd performance

Today’s low

Today’s high

₹ 464.35 ₹ 478.50
₹ 465.55

52 week low

52 week high

₹ 463.80 ₹ 499.00
₹ 465.55

Open Price

₹ 472.50

Prev. Close

₹ 471.25

Volume (Shares)

882414.00

Total traded value

₹ 4108.07

Upper Circuit

₹ 565.50

Lower Circuit

₹ 377.00

info

Nephrocare Health Services Ltd Share Price Update

As of the latest trading session, Nephrocare Health Services Ltd share price is currently at ₹ 465.95, which is down by ₹ -5.29 from its previous closing. Today, the stock has fluctuated between ₹ 464.35 and ₹ 478.50. Over the past year, Nephrocare Health Services Ltd has achieved a return of [-] %. In the last month alone, the return has been [-] %. Read More...

Nephrocare Health Services Ltd fundamentals


  • Market cap (Cr)

    4,671.40

  • P/E Ratio (TTM)

    0.00

  • Beta

    0.00

  • Book Value / share

    90.58

  • Return on equity

    6.02%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    4,684.90

  • P/E Ratio (TTM)

    0.00

  • Beta

    0.00

  • Book Value / share

    90.58

  • Return on equity

    6.02%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Nephrocare Health Services Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Book Value / Share 3288.65
ROE % 12.00
ROCE % 13.01
Total Debt to Total Equity 0.53
EBITDA Margin 23.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2345.99
ROE % 7.87
ROCE % 7.66
Total Debt to Total Equity 0.58
EBITDA Margin 19.33
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2213.96
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 12.48
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2254.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.29
EBITDA Margin 8.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 3051.81
ROE % 6.02
ROCE % 8.11
Total Debt to Total Equity 0.32
EBITDA Margin 20.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2291.71
ROE % 0.87
ROCE % 2.60
Total Debt to Total Equity 0.47
EBITDA Margin 13.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2260.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin 11.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2346.94
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.28
EBITDA Margin 6.77
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 155.38
Total Assets 996.46
Total Liabilities 996.46
Total Equity 584.11
Share Outstanding 2084718
Price to Book Ratio 0.00
Return on Assets (%) 6.73
Return on Capital (%) 8.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.17
Total Assets 806.01
Total Liabilities 806.01
Total Equity 413.70
Share Outstanding 2068740
Price to Book Ratio 0.00
Return on Assets (%) 4.35
Return on Capital (%) 5.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 127.30
Total Assets 666.23
Total Liabilities 666.23
Total Equity 388.63
Share Outstanding 1710167
Price to Book Ratio 0.00
Return on Assets (%) -1.76
Return on Capital (%) -2.02
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 143.36
Total Assets 571.28
Total Liabilities 571.28
Total Equity 395.99
Share Outstanding 1696168
Price to Book Ratio 0.00
Return on Assets (%) -3.73
Return on Capital (%) -4.17
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 33.42
Total Assets 756.61
Total Liabilities 756.61
Total Equity 542.00
Share Outstanding 1729270
Price to Book Ratio 0.00
Return on Assets (%) 4.52
Return on Capital (%) 5.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 664.57
Total Liabilities 664.57
Total Equity 404.21
Share Outstanding 1713292
Price to Book Ratio 0.00
Return on Assets (%) 0.58
Return on Capital (%) 0.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 646.89
Total Liabilities 646.89
Total Equity 396.64
Share Outstanding 1710167
Price to Book Ratio 0.00
Return on Assets (%) -2.39
Return on Capital (%) -2.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 128.06
Total Assets 571.90
Total Liabilities 571.90
Total Equity 411.99
Share Outstanding 1696168
Price to Book Ratio 0.00
Return on Assets (%) -3.84
Return on Capital (%) -4.17
Particulars MAR 2025 (Values in Cr)
Net Income 87.43
Cash from Operations 136.30
Cash from Investing -125.07
Cash from Financing 54.37
Net change in Cash 64.64
Free Cash Flow 236.07
Particulars MAR 2024 (Values in Cr)
Net Income 33.16
Cash from Operations 80.34
Cash from Investing -50.66
Cash from Financing 26.73
Net change in Cash 48.35
Free Cash Flow 157.69
Particulars MAR 2023 (Values in Cr)
Net Income -8.59
Cash from Operations 6.64
Cash from Investing -78.20
Cash from Financing 59.96
Net change in Cash -4.49
Free Cash Flow 78.21
Particulars MAR 2022 (Values in Cr)
Net Income -27.14
Cash from Operations 19.12
Cash from Investing -129.29
Cash from Financing 121.29
Net change in Cash 6.03
Free Cash Flow 97.47
Particulars MAR 2025 (Values in Cr)
Net Income 45.36
Cash from Operations 74.34
Cash from Investing -103.51
Cash from Financing 26.02
Net change in Cash 2.23
Free Cash Flow 154.10
Particulars MAR 2024 (Values in Cr)
Net Income 0.21
Cash from Operations 50.73
Cash from Investing -22.66
Cash from Financing -35.54
Net change in Cash -1.46
Free Cash Flow 122.59
Particulars MAR 2023 (Values in Cr)
Net Income -12.87
Cash from Operations 7.19
Cash from Investing -74.70
Cash from Financing 63.38
Net change in Cash -0.17
Free Cash Flow 43.97
Particulars MAR 2022 (Values in Cr)
Net Income -28.07
Cash from Operations 16.71
Cash from Investing -167.48
Cash from Financing 147.37
Net change in Cash -8.19
Free Cash Flow 59.68
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6917.30 59.49 10.94 99460.16 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 60.52 25.01 3.30 113.43 55.15 / 98.70
SHREE PACETRONIX LTD. 237.40 39.90 5.08 92.59 61.11 / 283.15
TRANSGENE BIOTEK LTD. 2.90 0.00 2.38 21.97 2.61 / 8.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6917.30 70.95 10.67 99460.16 6002.15 / 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 / 0.0
CHENNAI MEENAKSHI MULTISPECIAL 49.86 0.00 -14.48 37.25 28.34 / 57.48
KOVAI MEDICAL CENTER & HOSPITA 5853.35 28.01 5.38 6403.56 4810.20 / 6725.00

Nephrocare Health Services Ltd shareholding pattern

Holding

27.82%
63.85%
3.58%
4.73%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

Nephrocare Health Services Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
465.55 -1.20 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 471.30
  • 26 Days 471.30
  • 10 Days 471.30
  • 50 Days 471.30
  • 12 Days 471.30
  • 100 Days 471.30
  • 20 Days 471.30
  • 200 Days 471.30
478.02 PIVOT

First Support

457.03

First Resistance

492.23

Second Support

442.82

Second Resistance

513.22

Third Support

421.83

Third Resistance

527.43

RSI

0.00

ADX

0.00

MACD

0.00

Williams % R

-78.84

Commodity Channel Index (CCI)

0.00

Date

2025-12-17

Week

8511832.00

Same Day

8511832.00

Month

8511832.00

1 Year

0.0

3 Year

0.0

Over 1 Month

0.00%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Nephrocare Health Services Ltd Corporate Actions

Nephrocare Health Services Ltd Share Price

Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009. Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.

Company offer comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. The Company began journey in 2010 with the launch of its first dialysis clinic in Hyderabad. It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd. in 2018; launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc in 2020.

The Company acquired 6 clinics dialysis network with 35000 annual tretaments in 2023 . Further, it has acquired a chain of 7 clinics dialysis network such as AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc. in FY25.

Company is planning to raise funds of fresh issue of Rs 353.4 Cr equity shares having the face value of Rs 2/- each, by issuing 12,792,056 equity shares through offer for sale.

Parent organization Indian Private
NSE symbol NEPHROPLUS
Founded 2009
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nephrocare Health Services Ltd?

Answer Field

Nephrocare Health Services Ltd share price is for NSE ₹ 465.95 & for BSE ₹ 466.10 as on Dec 18 2025 03:07 PM.

What is the Market Cap of Nephrocare Health Services Ltd Share?

Answer Field

The market cap of Nephrocare Health Services Ltd for NSE ₹ 97.13 & for BSE ₹ 97.16 as on Dec 18 2025 03:07 PM.

What is the 52 Week High and Low of Nephrocare Health Services Ltd?

Answer Field

The 52 Week High and Low of Nephrocare Health Services Ltd for NSE is ₹ 499.00 and ₹ 463.80 and for BSE is ₹ 498.70 and ₹ 463.50.

What is 1 year return for Nephrocare Health Services Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Nephrocare Health Services Ltd Share?

Answer Field

As on Dec 18 2025 03:07 PM the price-to-earnings (PE) ratio for Nephrocare Health Services Ltd share is 0.00.

What is the PB ratio of Nephrocare Health Services Ltd Share?

Answer Field

As on Dec 18 2025 03:07 PM, the price-to-book (PB) ratio for Nephrocare Health Services Ltd share is 90.58.

How to Buy Nephrocare Health Services Ltd Share?

Answer Field

You can trade in Nephrocare Health Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nephrocare Health Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Nephrocare Health Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nephrocare Health Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59